Gilead sciences stock price.
The Dividend Yield % of Gilead Sciences Inc (GILD) is 3.94% (As of Today), Highest Dividend Payout Ratio of Gilead Sciences Inc (GILD) was 0.78. The lowest was 0.11. And the median was 0.49. The Forward Dividend Yield % of Gilead Sciences Inc (GILD) is 3.96%. For more information regarding to dividend, please check our Dividend Page .
At first glance, this description fits Gilead Sciences (GILD-0.81%), one of the largest biotechs in the world with a forward price-to-earnings (P/E) ratio of 10, compared to the industry's average ...Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet ... Consensus Price Target is the stock price ...As a leader in various therapeutic areas, Gilead Sciences' total revenue was $7,042 million in Q3 2022, up 12.5% QoQ. Read why I rate GILD stock a Sell.Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 United States 650 574 3000 https://www.gilead.com Sector(s) : Healthcare Industry : Drug Manufacturers - General Full Time Employees ...
To wit, the Gilead Sciences, Inc. (NASDAQ:GILD) share price is 28% higher than it was a year ago, much better than the market return of around 4.2% (not including dividends) in the same period ...
Get the latest Gilead Sciences, Inc. (GILD) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financial results, earnings, cash flow, balance sheet, and shareholder data for the second quarter of 2023.
Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Gilead Sciences, Inc. Type, Public · Traded as · Nasdaq ...Gilead Sciences is still deeply undervalued, which should lead to higher stock prices in the coming quarters. But maybe a catalyst is necessary to driver the stock price higher.Feb 6, 2023 · Shares of Gilead Sciences (GILD 1.30%) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug ... Mar 3, 2023 · Gilead Sciences (GILD) closed at $81.07 in the latest trading session, marking a +1.82% move from the prior day. This change outpaced the S&P 500's 1.62% gain on the day.
Despite a 25% decline in Gilead Sciences stock since late April this year, at the current price of just over $60, we believe GILD stock has more downside. Why is that? This can be attributed to ...
According to 14 stock analysts, the average 12-month stock price forecast for GILD stock stock is $89.36, which predicts an increase of 18.55%. The lowest target is $71 and the highest is $112. On average, analysts rate GILD stock stock as a buy.
Gilead Sciences, Inc. price-consensus-chart | Gilead Sciences, Inc. Quote. Despite this positive trend, the stock has a Zacks Rank #3 (Hold), which indicates expectations of in-line performance ...77.89. 76.40. 4,877,200. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly formats back to when Gilead Sciences, Inc. stock was issued.Real time Exact Sciences (EXAS) stock price quote, stock graph, news & analysis. Accessibility Log In ... Gilead Sciences. Market Cap. $94B. Current Price. $75.38. NASDAQ: ILMN Illumina. Market Cap.In a report released today, Carter Gould from Barclays maintained a Hold rating on Gilead Sciences ( GILD – Research Report ), with a price target of $81.00. The company’s shares closed ...Interactive Chart for Gilead Sciences, Inc. (GILD), analyze all the data with a huge range of indicators. Home; Mail; ... NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W ...
Price as of November 24, 2023, 1:00 p.m. ET. ... Gilead Sciences (GILD-0.42%) stock has been a standout among biotech companies over the past year, with its shares up more than 36%.Dec 1, 2023 · Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Gilead Sciences Inc. 333 Lakeside Drive. Foster City, California 94404. Phone 1 650 574-3000. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023.Get the latest Gilead Sciences, Inc. (GILD-USD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.Gilead Sciences (GILD) Quote Overview ... While the F1 consensus estimate and revision is a key driver of stock prices, the Q1 consensus is an important item as well, especially over the short ...NASDAQ Composite Index, S&P 500, NASDAQ 100, S&P 400 MidCap, S&P 100, BX Swiss - USA. GILEAD SCIENCES AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Gilead Sciences Inc. | 885823 | GILD ...
Gilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $116.00: Low: $71. ...As a leader in various therapeutic areas, Gilead Sciences' total revenue was $7,042 million in Q3 2022, up 12.5% QoQ. Read why I rate GILD stock a Sell.
Nov 27, 2023 · Get Gilead Sciences Inc (GILD.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Sep-07-23 08:55PM. Gilead Prices $2 Billion of Senior Unsecured Notes. (Business Wire) 06:00PM. Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know. (Zacks) Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.As a leader in various therapeutic areas, Gilead Sciences' total revenue was $7,042 million in Q3 2022, up 12.5% QoQ. Read why I rate GILD stock a Sell.MarketBeat. 1 day ago. Crawford Investment Counsel Inc. Has $28.53 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) NDAQ. 0.11%. 1.37%. Investor's Business Daily. …What was the 52-week low for Gilead Sciences stock? The low in the last 52 weeks of Gilead Sciences stock was 72.87. According to the current price, Gilead Sciences is 106.57% away from the 52 ... Gilead Sciences is still deeply undervalued, which should lead to higher stock prices in the coming quarters. But maybe a catalyst is necessary to driver the stock price higher.
About the Gilead Sciences, Inc. stock forecast. As of 2023 November 26, Sunday current price of GILD stock is 75.380$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Gilead Sciences stock price has been showing a declining tendency so we believe that similar market …
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet ... Consensus Price Target is the stock price ...
On December 4, 2023, GILD, the stock of biopharmaceutical company Gilead Sciences, demonstrated mixed performance as it traded near the bottom of its 52-week range and close to its 200-day simple moving average. This information provides insights into the stock’s price momentum and recent price changes.Anavex Life Sciences (AVXL) stock is rocketing higher on Friday following positive results from an Alzheimer’s treatment clinical trial. AVXL is closer to approval for its Alzheimer’s drug Anavex Life Sciences (NASDAQ:AVXL) stock is rocketi...Dec 1, 2023 · CI. Arcellx, Inc. announced that it expects to receive $199.999991 million in funding from Gilead Sciences, Inc. Nov. 14. CI. RBC Trims Price Target on Gilead Sciences to $77 From $78, Keeps Sector Perform Rating. Nov. 14. MT. UBS Adjusts Price Target on Gilead Sciences to $81 From $85, Maintains Neutral Rating. Nov. 13. Gilead sciences discounted cash flow analysis (my table and assumptions) ... My final price target for Gilead stock in 2023 is therefore the average of DCF / EBITDA multiple, which is $112 per ...To opt-in for investor email alerts, please: Enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.In July, I set a price target for Gilead stock of ~$125 - I am revising that figure down to ~$112, after completing revised forward revenue projections. ... Gilead sciences discounted cash flow ...Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. To opt-in for investor email alerts, please: Enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.Gilead Sciences Inc. research and ratings by Barron's. View GILD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... Stock Price Target. High: $116.00: Low: $71. ...Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced. By Annalee Armstrong Nov 29, 2023 8:01am. Gilead Sciences Kite Pharma …We estimate Gilead Sciences’ valuation to be $62, aligning with its current market price. Although GILD stock is trading at a lower P/S multiple compared to the levels seen in 2017, it is ...The Gilead stock price gained 1.37% on the last trading day (Friday, 1st Dec 2023), ... (+/-1.79%) up or down from last closing price. If Gilead Sciences takes out the full calculated possible swing range there will be an estimated 3.58% move between the lowest and the highest trading price during the day. ...
Get Gilead Sciences Inc historical price data for GILD stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Gilead Sciences, Inc. (GILD) stock forecast and price target. Find the latest Gilead Sciences, Inc. GILD analyst stock forecast, price target, and recommendation trends with in-depth analysis from ... Instagram:https://instagram. xomoho2 homeowners policyprovident financialcinemark concessions Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.GILD Stock Summary. GILD has a higher market value than 97.69% of US stocks; more precisely, its current market capitalization is $94,599,500,668. GILD's went public 31.83 years ago, making it older than 83.17% of listed US stocks we're tracking. open demo trading accountfidelity zero total market index As of September 26, 2023, Gilead Sciences ( NASDAQ:GILD) is trading at $76.19, with a market cap of $94.90 billion, and sales of $27.40 billion. The company's GF Value, a measure of its intrinsic ... kre dividend Dec 1, 2023 · Based on short-term price targets offered by 19 analysts, the average price target for Gilead Sciences comes to $89.68. The forecasts range from a low of $71.00 to a high of $115.00. Biotech giant Gilead Sciences (GILD 0.65%) has a lot going its way, including the company's juicy dividend yield of 4.7%. ... Stock Advisor list price is $199 per year.